CVS Health is reported to be moving toward a corporate break-up that would create two separate, publicly traded companies. Multiple outlets say the separation would separate the company’s pharmacy business from its insurance operations, though the exact structure and timeline are described as pending.
The reports frame the move as a reversal of CVS’s long-running strategy of building an integrated healthcare business. Financial Times coverage links the potential spin-off to political scrutiny of pharmacy benefit managers and health insurers, while other reporting highlights the role of earlier acquisitions in building the current structure.
Details across sources differ mainly in emphasis: some focus on the business components that would be separated, others on the reported political pressure driving the change. One outlet also points to a target timeframe for completing the split, reporting it could occur by 2028. Overall, the outlets broadly agree on the core idea of dismantling the integrated empire into two parts.
